Cantargia AB vs Immunic Therapeutics
Immunic Therapeutics
Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases
91 employees · est. 2016 · United States
Cantargia AB is the older company (2010 vs 2016); Immunic Therapeutics is the larger of the two.
3 signals in the last 90 days
Side-by-Side Comparison
| Metric | Cantargia AB | Immunic Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2010 older | 2016 |
| Headquarters | ||
| Headquarters | Lund, Sweden | United States |
| Employees | ||
| Employees | 32 | 91 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Medical Devices | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $257.00M | $520.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 10 |
| Taxonomy | ||
| Taxonomy | Antibody-based TherapiesClinical ProgramsIL1RAPCancer TreatmentAutoimmune DiseasesInflammatory Diseases +8 | Small Molecule TherapiesChronic Inflammatory DiseasesAutoimmune DiseasesClinical PipelineOral AdministrationNasdaq Listed +5 |
| Website | ||
| Website | cantargia.com | imux.com |
About Cantargia AB
Cantargia is a Swedish listed biotechnology company that focuses on developing antibody-based therapies targeting IL1RAP. The company's clinical programs include nadunolimab, which is currently in phase II development for the treatment of cancer, and CAN10 in phase I development for autoimmune/infla...
About Immunic Therapeutics
Immunic Therapeutics is a biotechnology company founded in 2016 and headquartered in the United States. The company's focus lies in the development of small molecule therapies for chronic inflammatory and autoimmune diseases. Immunic, listed on Nasdaq under the ticker symbol IMUX, boasts a clinical...
Also comparing in this category
Comparing more than these two?
Get Cantargia AB, Immunic Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Cantargia AB compare?
A PDF of Cantargia AB and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Cantargia AB with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cantargia AB on 12 Sep 2024, and Immunic Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
